Medical Equipment

Balloon Valvuloplasty Device Market Industry Outlook 2026–2030 Highlighting Growth Momentum And Market Trends

May 11, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Balloon Valvuloplasty Device Market Projected To Expand During 2026–2030?

The balloon valvuloplasty device market size has demonstrated robust expansion in recent years. This market is set to expand from $2.57 billion in 2025 to $2.73 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.9%. The historical growth can be ascribed to several factors, including an increase in the prevalence of cardiac valve stenosis, the prompt adoption of minimally invasive interventional cardiology procedures, the innovation of standard and compliant balloon technologies, the expansion of hospital-based cardiac catheterization laboratories, and growing treatment volumes in pediatric congenital heart cases.

The balloon valvuloplasty device market size is anticipated to experience robust expansion over the coming years. It is projected to reach $3.35 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.3%. This growth during the forecast period can be linked to factors such as an expanding aging population suffering from aortic and mitral valve stenosis, an increasing need for high-pressure and scoring balloon devices, broader application of balloon valvuloplasty in ambulatory and specialty clinic settings, a growing move towards non-surgical cardiac treatment options, and continuous advancements in balloon materials and device design. Key trends anticipated for the forecast period encompass a rising inclination towards minimally invasive valve repair methods, an increased uptake of balloon valvuloplasty as an alternative to traditional open-heart surgery, enhanced deployment in both pediatric and adult congenital heart valve conditions, an expansion of valve dilation procedures within specialized cardiology centers, and a concentrated effort on bettering patient results and achieving quicker recovery times.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17090&type=smp

Which Growth Factors Are Strengthening The Balloon Valvuloplasty Device Market Landscape?

The increasing preference for minimally invasive procedures is projected to fuel the expansion of the balloon valvuloplasty device market moving forward. Minimally invasive procedures involve medical techniques carried out through small incisions or natural body orifices, leading to reduced trauma and promoting faster recovery compared to traditional surgeries. The demand for minimally invasive procedures is growing due to their shorter recovery periods, lower risk of complications, and diminished post-operative pain in contrast to conventional surgeries. Balloon valvuloplasty devices are employed in minimally invasive surgical procedures to widen narrowed heart valves, improve blood flow, and alleviate symptoms. For instance, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported the placement of 415 da Vinci surgical systems (robotic surgical systems that use a minimally invasive surgical approach) in the fourth quarter of 2023, representing a 12% increase compared to 2022. Therefore, the rising inclination towards minimally invasive procedures is driving the growth of the balloon valvuloplasty device market.

How Is The Balloon Valvuloplasty Device Market Structured Across Different Market Segments?

The balloon valvuloplasty device market covered in this report is segmented –

1) By Product Type: Standard Balloon, Cutting Balloon, Scoring Balloon, High-Pressure Balloon, Low-Pressure Balloon

2) By Age Group: Pediatric, Adult

3) By End-use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Standard Balloon: Non-Compliant Balloons, Compliant Balloons

2) By Cutting Balloon: Single-Cutting Balloon, Multi-Cutting Balloon

3) By Scoring Balloon: Single-Score Balloons, Dual-Score Balloons

4) By High-Pressure Balloon: Non-Compliant High-Pressure Balloons, Compliant High-Pressure Balloons

5) By Low-Pressure Balloon: Semi-Compliant Low-Pressure Balloons, Non-Compliant Low-Pressure Balloons

What Trends Are Influencing The Future Of The Balloon Valvuloplasty Device Market?

Leading companies in the balloon valvuloplasty device market are concentrating on developing advanced products, such as Pacing Guidewires, to gain a competitive advantage. A pacing guidewire is a specialized wire utilized to provide temporary cardiac pacing during the procedure, ensuring the heart maintains a stable rhythm while the balloon catheter is inserted and inflated to dilate the narrowed valve. For instance, in June 2023, Teleflex Incorporated, a US-based medical device company, received clearance from the Food and Drug Administration (FDA) for the Wattson Temporary Pacing Guidewire. This new device is specifically designed for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV) procedures. The Wattson Temporary Pacing Guidewire offers dual functionality, supporting both valve delivery and ventricular bipolar pacing during these structural heart procedures. Its flexible distal pigtail shape, multiple electrodes, and bipolar design are engineered to help reduce the risk of ventricular perforation while providing reliable electrical capture during rapid pacing.

Who Are The Businesses Driving Activity In The Balloon Valvuloplasty Device Market?

Major companies operating in the balloon valvuloplasty device market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Edwards Lifesciences Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical Incorporated, Balton Sp z o o, Meril Life Sciences Pvt Ltd, JenaValve Technology Inc, Osypka Medical GmbH, Scitech Medical, Translumina GmbH, AndraTec GmbH, Palex Medical SA, Biosensors International Group Ltd, Hexacath, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, QT Vascular Ltd

Access The Complete Balloon Valvuloplasty Device Market Report:

https://www.thebusinessresearchcompany.com/report/balloon-valvuloplasty-device-global-market-report

Which Region Accounts For The Highest Share Of The Balloon Valvuloplasty Device Market?

North America was the largest region in the balloon valvuloplasty device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon valvuloplasty device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Balloon Valvuloplasty Device Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=17090&type=smp

Browse Through More Reports Similar to the Global Balloon Valvuloplasty Device Market 2026, By The Business Research Company

Angioplasty Balloons Market Report 2026

https://www.thebusinessresearchcompany.com/report/angioplasty-balloons-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Pta Balloon Catheter Market Report 2026

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795